Financial Performance - Flywire (FLYW) reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.01, compared to a loss of $0.12 per share a year ago, representing an earnings surprise of +100.00% [1] - The company posted revenues of $152.7 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 6.17%, and up from $112.8 million year-over-year [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.02 on revenues of $154.41 million, and for the current fiscal year, it is $0.28 on revenues of $686.21 million [7] - The estimate revisions trend for Flywire was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Internet - Software industry, to which Flywire belongs, is currently in the top 38% of over 250 Zacks industries, suggesting that companies in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, PubMatic, is expected to report a quarterly earnings decline of -61% year-over-year, with revenues projected to decrease by 12.2% from the previous year [9]

MGE (MGEE) came out with quarterly earnings of $0.64 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.61 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this public utility holding company would post earnings of $1.19 per share when it actually produced earnings of $1.22, delivering a surprise of +2.52%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.MGE, which belongs ...

Core Viewpoint - Xometry reported quarterly earnings of $0.16 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, and showing significant growth from $0.06 per share a year ago, indicating a positive earnings surprise of +33.33% [1] Financial Performance - The company achieved revenues of $192.4 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 4.94%, and up from $148.55 million in the same quarter last year [2] - Over the last four quarters, Xometry has exceeded consensus EPS estimates three times and topped revenue estimates four times [2] Stock Performance and Outlook - Xometry shares have declined approximately 3.9% since the beginning of the year, contrasting with the S&P 500's slight decline of 0.1% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.15 on revenues of $184.13 million, and for the current fiscal year, it is $0.83 on revenues of $815.57 million [7] - The estimate revisions trend for Xometry was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Manufacturing - General Industrial industry, to which Xometry belongs, is currently ranked in the top 29% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.22%. A quarter ago, it was expected that this company would post earnings of $0.22 per share when it actually produced earnings of $0.26, delivering a surprise of +18.18%.Over the last four quarters, the co ...

Option Care (OPCH) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.63%. A quarter ago, it was expected that this infusion and home care services company would post earnings of $0.43 per share when it actually produced earnings of $0.45, delivering a surprise of +4.65%.Over the last four quarter ...

Core Viewpoint - Tennant (TNC) reported quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $1.68 per share, and down from $1.52 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was -17.02%, and the company has not surpassed consensus EPS estimates over the last four quarters [2] - Revenues for the quarter were $291.6 million, missing the Zacks Consensus Estimate by 8.7%, and down from $328.9 million year-over-year [3] Stock Performance - Tennant shares have increased by approximately 13.1% since the beginning of the year, compared to a 0.9% gain in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.35 on revenues of $301.05 million, and for the current fiscal year, it is $6.64 on revenues of $1.29 billion [8] - The Zacks Rank for Tennant is currently 3 (Hold), indicating expected performance in line with the market in the near future [7] Industry Context - The Manufacturing - General Industrial industry, to which Tennant belongs, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [9]

Offerpad Solutions Inc. (OPAD) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +7.14%. A quarter ago, it was expected that this company would post a loss of $0.29 per share when it actually produced a loss of $0.34, delivering a surprise of -17.24%.Over the last four quarters, the company h ...

分组1 - GeneDx Holdings Corp. reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.11 per share, and showing a year-over-year decrease from $0.7 per share [1] - The company achieved revenues of $120.99 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.50% and increasing from $95.64 million year-over-year [2] - GeneDx Holdings has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed, losing approximately 36.9% since the beginning of the year, while the S&P 500 has gained 0.9% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.09 on revenues of $115.8 million, and for the current fiscal year, it is $0.58 on revenues of $526.5 million [7] - The Medical Services industry, to which GeneDx belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, which may impact stock performance [8]

分组1 - ICU Medical reported quarterly earnings of $1.91 per share, exceeding the Zacks Consensus Estimate of $1.68 per share, but down from $2.11 per share a year ago, representing an earnings surprise of +13.52% [1] - The company achieved revenues of $535.94 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.32%, but down from $621.62 million year-over-year [2] - ICU Medical has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has gained approximately 6.3% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.78 on revenues of $522.55 million, and for the current fiscal year, it is $7.96 on revenues of $2.17 billion [7] - The Zacks Industry Rank for Medical - Products is currently in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]

分组1 - Select Medical reported quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.23 per share, and down from $0.18 per share a year ago, representing an earnings surprise of -31.57% [1] - The company posted revenues of $1.4 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.60%, and up from $1.31 billion year-over-year [2] - Select Medical has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has gained about 9.9% since the beginning of the year, compared to the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the coming quarter is $0.42 on revenues of $1.42 billion, and for the current fiscal year, it is $1.34 on revenues of $5.64 billion [7] - The Zacks Industry Rank for Medical - HMOs is currently in the bottom 9% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]